{
    "2020-06-08": [
        [
            {
                "time": "2020-06-08",
                "original_text": "康龙化成(03759.HK)实际控制人及其一致行动人质押615.6万股及解除质押630.25万股",
                "features": {
                    "keywords": [
                        "康龙化成",
                        "实际控制人",
                        "一致行动人",
                        "质押",
                        "解除质押"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-06-08",
                "original_text": "康龙化成(300759.SZ)：北京多泰及楼小强合计质押615.6万股楼小强及龙泰康合计解押630.25万股",
                "features": {
                    "keywords": [
                        "康龙化成",
                        "北京多泰",
                        "楼小强",
                        "质押",
                        "解押"
                    ],
                    "sentiment_score": -0.1,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-06-08",
                "original_text": "医药生物行业周报：全球疫情持续 API和CDMO二季度超预期机会明显",
                "features": {
                    "keywords": [
                        "医药生物",
                        "全球疫情",
                        "API",
                        "CDMO",
                        "二季度",
                        "超预期"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-06-08",
                "original_text": "【权益变动】康龙化成(03759-HK)被国企结构调整基金减持25.96万股 减持股份",
                "features": {
                    "keywords": [
                        "康龙化成",
                        "国企结构调整基金",
                        "减持"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-06-08",
                "original_text": "A股早报2020年6月8日星期一",
                "features": {
                    "keywords": [
                        "A股早报"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}